Patent directory · USPTO A61K / A61P
Patents matching “626”
162 pharma patents match "626" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 162 pharmaceutical patents matching "626" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
WO 2026057626
PEPTIDOGLYCANE HYDROLASES AYANT DE MULTIPLES DOMAINES ENZYMATIQUEMENT ACTIFS
granted -
US 12383626
Polyoxazoline-drug conjugates with novel pharmacokinetic properties
granted -
US 12178626
Encapsulated gas or partial vacuum CT contrast material
granted -
US 12036269
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
granted -
US 12036266
Activatable cytokine polypeptides and methods of use thereof
granted -
US 11944626
Small molecule inhibitors of ALDH and uses thereof
granted -
US 11925626
Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound
granted -
US 11896626
Multistrain population control systems and methods
granted -
US 11891626
Isolated discogenic cells, methods of using, and methods of preparing same from mammalian tissue
granted -
US 11684626
Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
granted -
US 11566263
Compositions and methods for treating CEP290 associated disease
granted -
US 11466261
Mutated PTE enzymes
granted -
US 11376263
Cyproterone acetate compositions and uses thereof
granted -
US 11344626
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
granted -
US 11286265
Macrocyclic compounds for treating disease
granted -
US 11286264
Macrocyclic compounds and uses thereof
granted -
US 11278626
Compositions of polymeric nanowires and methods of making and using thereof
granted -
US 11224626
Methods of identifying bacteriophages that can infect and kill host-adapted infectious pathogenic bacteria
granted -
US 11219626
Pharmaceutical compositions comprising meloxicam
granted -
US 11186626
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
granted -
CA 3162611
COMPLEXES DE FER ET SELS DE CEUX-CI UTILISES EN TANT QU'AGENTS DE CONTRASTE POUR IRM
granted -
US 11033626
Progesterone formulations having a desirable pk profile
granted -
US 11006626
Compounds for protection of cells
granted -
US 10940626
Manufacturing of small film strips
granted